January « 2014 « Science and Enterprise

Techniques Boost Range, Accuracy of Wireless ID Signals

By Alan, on January 23rd, 2014%

Sabesan Sithamparanathan (Girton College, University of Cambridge)

Engineers at University of Cambridge in the U.K. developed techniques to vastly improve the range and accuracy of passive radio-frequency identification (RFID) tags used to identify passports, luggage, and goods in transit. The team led by Cambridge research fellow Sabesan Sithamparanathan published its findings online in the . . . → Read More: Techniques Boost Range, Accuracy of Wireless ID Signals

FDA Fast-Track Granted to Cancer Therapy Side-Effects Drug

By Alan, on January 23rd, 2014%

(National Institutes of Health)

BioAlliance Pharma SA in Paris says its drug candidate to treat inflammation of the mucus membranes in the mouth, resulting from chemo- or radiation therapy to treat cancer, received fast-track status from the U.S. Food and Drug Administration. Validive, the drug’s brand name, is designed for patients with head . . . → Read More: FDA Fast-Track Granted to Cancer Therapy Side-Effects Drug

Synthetic Bio Platform Finds Potential Superbug Antibiotic

By Alan, on January 22nd, 2014%

Scanning electron micrograph of Saccharomonospora bacteria (National Library of Medicine)

Researchers at University of California in San Diego created a process for cloning synthetic gene clusters from marine bacteria that generate molecules with therapeutic potential, and produced an antibiotic candidate to treat previously drug-resistant infections. The team led by UC-San Diego oceanography and . . . → Read More: Synthetic Bio Platform Finds Potential Superbug Antibiotic

Cancer Organizations, Biotech Partner on Drug Discovery

By Alan, on January 22nd, 2014%

(James. J. Caras, National Science Foundation)

Institute of Cancer Research and Cancer Research Technology in London, and the drug discovery company Nuevolution A/S in Copenhagen, are collaborating on identifying leads for new cancer treatments that act on a promising biological pathway. The agreement includes the option to co-develop therapies from candidates identified in . . . → Read More: Cancer Organizations, Biotech Partner on Drug Discovery

Simple, Sensitive Biosensors Derived from Engineered Viruses

By Alan, on January 21st, 2014%

Seung-Wuk Lee (Univ of California, Berkeley)

Bioengineers at University of California in Berkeley developed a process for making sensors from genetically-engineered viruses simple enough to package in a smartphone app, yet can discriminate among volatile chemical vapors. The team from the lab of bioengineering professor Seung-Wuk Lee, with colleagues from Lawrence Berkeley National Lab . . . → Read More: Simple, Sensitive Biosensors Derived from Engineered Viruses

Trial Underway Testing Head-Neck Cancer Immunotherapy

By Alan, on January 21st, 2014%

Human papillomavirus (National Cancer Institute)

Advaxis Inc., a biopharmaceutical company in Princeton, New Jersey, began dosing the first patient in clinical trial testing a therapy that harnesses the immune system to treat head and neck cancer caused by the human papillomavirus, or HPV. The therapy is designed as part of a therapy strategy . . . → Read More: Trial Underway Testing Head-Neck Cancer Immunotherapy

EU-Funded Project to Develop Biomaterials for Stents

By Alan, on January 20th, 2014%

Stent for aortic valve replacement (National Heart, Lung, and Blood Institute)

Ceram, a materials technology company in Stoke-on-Trent in the U.K., is coordinating a project funded by the European Commission to develop new biocompatible materials suitable for stents that help keep blood vessels open in the heart. The project, known as Rebiostent, is . . . → Read More: EU-Funded Project to Develop Biomaterials for Stents

Challenge Seeks Ways to Make Trace Minerals More Available

By Alan, on January 17th, 2014%

(A. Kotok)

A new challenge on InnoCentive is looking for different methods for making more available in people’s diets minerals the body needs in small quantities. The competition has a total guaranteed purse of $7,000, with a deadline for submissions of 15 February 2014.

InnoCentive in Waltham, Massachusetts conducts open-innovation, crowd-sourcing competitions for corporate . . . → Read More: Challenge Seeks Ways to Make Trace Minerals More Available

European Venture Licenses Biotech Drought-Resistant Traits

By Alan, on January 17th, 2014%

(USDA.gov)

Genective, a joint venture between German and French seed companies to develop new corn varieties, is licensing engineered gene science from the biotechnology company Arcadia Biosciences Inc. in Davis, California. Arcadia Biosciences will receive initial, milestone, and sales royalty payments under the agreement, but the dollar amount of the deal was not . . . → Read More: European Venture Licenses Biotech Drought-Resistant Traits

Drugs Found with Potential to Replace Traumatic Memories

By Alan, on January 16th, 2014%

Li-Huei Tsai (Massachusetts Institute of Technology)

Neuroscientists at Massachusetts Institute of Technology found a class of drug compounds, some of which are now in use, can erase fear-causing memories in lab mice, and thus could treat post-traumatic stress disorder. The team from the lab of Li-Huei Tsai in MIT’s Picower Institute for Learning . . . → Read More: Drugs Found with Potential to Replace Traumatic Memories

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise